IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

PSP Research LLC

Portfolio Profile

CIK: 0002106939 | LAS VEGAS, NV

Investment Profile

Style

ETF

Turnover

Medium

Orientation

Concentrated trader
$145.8M
AUM
44
Positions
94.97%
Top 10 Conc.
97.58%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Ishares TR(SGOV)700,000$70.5M48.33%
2Spdr Series Trust(XBI)386,500$60.9M41.79%
3Sera Prognostics Inc(SERA)2,396,685$5.0M3.43%
4Halozyme Therapeutics Inc(HALO)3,000$331.2K0.23%
5Madrigal Pharmaceuticals Inc(MDGL)600$302.4K0.21%
6

Sector Allocation

Latest filing, equity positions only

Unclassified90.32% · $131.7M
Healthcare9.68% · $14.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare13.39%9.68%-3.71%
Unclassified86.61%90.32%+3.71%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$114.4M | 85 pos.
$141.3M | 79 pos.
$187.9M | 75 pos.
$145.8M | 44 pos.
Q4
25
Q1
26
Q2
26
Q3
26
Exelixis Inc(EXEL)
5,000
$292.1K
0.20%
7Royalty Pharma PLC(RPRX)5,000$291.8K0.20%
8Argenx SE(ARGX)300$287.7K0.20%
9Nurix Therapeutics Inc(NRIX)12,000$284.5K0.20%
10TG Therapeutics Inc(TGTX)5,000$278.9K0.19%
Cap SizePrev %Curr %Change
Unclassified86.61%90.32%+3.71%
Micro Cap0%3.43%+3.43%
Mid Cap6.7%3.15%-3.55%
Small Cap4.41%1.83%-2.58%
Large Cap2.28%1.27%-1.01%

Recent Activity

Quarter-over-quarter position changes

1
New
32
Closed
0
Increased
27
Decreased
16
Unchanged